Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1:20
Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC …
Feb 21, 2024
targetedonc.com
Adagrasib Demonstrates Superiority in KRAS G12C NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Adagrasib Demonstrates Superiority in KRAS G12C NSCLC | Targeted …
Oct 4, 2024
targetedonc.com
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | OncLive
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | …
2 weeks ago
onclive.com
Phase 1 Study Shows Potential of LY3537982 in KRAS G12C NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Phase 1 Study Shows Potential of LY3537982 in KRAS G12C NSCLC …
Aug 6, 2023
targetedonc.com
Innovations within Precision Oncology Evolution of a Biomarker a Case Study of KRAS-G12C
Innovations within Precision Oncology Evolution of a Biomarke…
May 12, 2022
questdiagnostics.com
Sotorasib: Mechanism of Action
0:16
Sotorasib: Mechanism of Action
150 views11 months ago
YouTubeLegacius Pharma
Dr Jänne on the Investigation of RMC-6291 in KRAS G12C-Mutated Solid Tumors | OncLive
Dr Jänne on the Investigation of RMC-6291 in KRAS G12C-Mutated …
Nov 7, 2023
onclive.com
Treatment of KRAS G12C Mutant NSCLC
May 11, 2022
onclive.com
Overview of KRAS G12C Mutations in NSCLC | AJMC
Jul 6, 2022
ajmc.com
Dr. Patil on the Development of KRAS G12C Inhibitors in Lung Ca…
Sep 13, 2021
onclive.com
Therapeutic Options for mCRC with KRAS G12C Mutations
Apr 25, 2024
onclive.com
Non–Small Cell Lung Cancer: Optimizing the Identification of KR…
Dec 9, 2022
onclive.com
Dr. Klempner on the Significance of KRYSTAL-1 Data in KRAS G12C–…
Nov 9, 2022
onclive.com
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (R…
4 months ago
vumedi.com
Dr Eng on the Implications of a Real-World Study in KRAS G12C–Mutat…
6 months ago
onclive.com
1:27
Clinical Perspectives of KRAS G12C Inhibitors in NSCLC Mutations | O…
Dec 7, 2023
onclive.com
What's Happening in KRAS G12C NSCLC? | OncLive
Apr 9, 2021
onclive.com
Treating ALK-Mutant and KRAS G12C–Mutant NSCLC | OncLive
2K viewsNov 19, 2021
onclive.com
Dr Hong on Preliminary Activity With RMC-6291 in Advanced KRA…
Oct 18, 2023
onclive.com
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Tria…
2 weeks ago
onclive.com
KRAS, EGFR, and the Future of Lung Cancer Treatment
11 months ago
medscape.com
KRAS G12C Inhibition in Non-Small Cell Lung Cancer
Dec 19, 2020
findkrasg12c.com
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC | On…
2 weeks ago
onclive.com
Dr Sabari on Preliminary Data From a Phase 1 Study of LY3537982 in …
Apr 17, 2023
onclive.com
Verastem Oncology Provides a Clinical Update for RAMP 203 Tria…
Dec 18, 2024
marketscreener.com
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designatio…
6 months ago
fox4kc.com
Dr Murciano-Goroff on the Investigation of KRAS G12C Inhibi…
Apr 28, 2023
onclive.com
3:47
The Current and Evolving Role of KRAS G12C and Pan-KRAS Inhibit…
2 weeks ago
onclive.com
0:12
Merck's MK-1084: KRAS G12C Inhibitor in Colorectal and Lung C…
368 views9 months ago
YouTubeMCQ Pedia
Dr Strickler on the Efficacy of Sotorasib Plus Panitumumab/Che…
9 months ago
onclive.com
See more videos
Static thumbnail place holder